Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Risk Factors for Suicidal Ideation in Patients Feeling Severely Affected by Multiple Sclerosis.
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
Retrograde retinal damage after acute optic tract lesion in MS.
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
Effective communication at the point of multiple sclerosis diagnosis.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination During Proteasomal Degradation.
Adult myelination: wrapping up neuronal plasticity.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Undifferentiated MSCs are able to myelinate DRG neuron processes through p75.
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Acute Disseminated Encephalomyelitis Without Optic Neuritis Followed by Optic Neuritis in a Child Due to the Sudden Cessation of Steroid Therapy.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis.
Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.
Late-onset Multiple Sclerosis in Isfahan, Iran.
Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »